Lataa...
Efficacy and safety of thalidomide in patients with hepatocellular carcinoma
AIM: To evaluate which patients with hepatocellular carcinoma (HCC) are most likely to respond to thalidomide treatment. METHODS: From July 2002 to July 2004, patients with HCC who received thalidomide treatment, were enrolled. We extracted relevant data from the patients’ medical records, including...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Co., Limited
2006
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4087338/ https://ncbi.nlm.nih.gov/pubmed/17109516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v12.i43.6955 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|